Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher B McLeland

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|December 1, 2010
Autophagy monitoring assay: qualitative analysis of MAP LC3-I to II conversion by immunoblotChristopher B McLeland, Jamie Rodriguez, Stephan T Stern
Methods in Molecular Biology (Clifton, N.J.)|October 18, 2017
Assessing NLRP3 Inflammasome Activation by NanoparticlesBhawna Sharma, Christopher B McLeland, Timothy M Potter, et al.
Advanced Drug Delivery Reviews|April 21, 2009
Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacyParag Aggarwal, Jennifer B Hall, Christopher B McLeland, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 18, 2008
Induction of autophagy in porcine kidney cells by quantum dots: a common cellular response to nanomaterials?Stephan T Stern, Banu S Zolnik, Christopher B McLeland, et al.
Clinical Chemistry|August 21, 2003
Development and assessment of a quantitative reverse transcription-PCR assay for simultaneous measurement of four ampliconsMarcy B Grace, Christopher B McLeland, Steven J Gagliardi, et al.
Cancer Research|September 18, 2004
Human in vivo radiation-induced biomarkers: gene expression changes in radiotherapy patientsSally A Amundson, Marcy B Grace, Christopher B McLeland, et al.
Cancer Letters|May 14, 2013
Synergistic combination therapy with nanoliposomal C6-ceramide and vinblastine is associated with autophagy dysfunction in hepatocarcinoma and colorectal cancer modelsPavan P Adiseshaiah, Jeffrey D Clogston, Christopher B McLeland, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|December 1, 2010
Autophagy monitoring assay: qualitative analysis of MAP LC3-I to II conversion by immunoblotChristopher B McLeland, Jamie Rodriguez, Stephan T Stern
Methods in Molecular Biology (Clifton, N.J.)|October 18, 2017
Assessing NLRP3 Inflammasome Activation by NanoparticlesBhawna Sharma, Christopher B McLeland, Timothy M Potter, et al.
Advanced Drug Delivery Reviews|April 21, 2009
Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacyParag Aggarwal, Jennifer B Hall, Christopher B McLeland, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 18, 2008
Induction of autophagy in porcine kidney cells by quantum dots: a common cellular response to nanomaterials?Stephan T Stern, Banu S Zolnik, Christopher B McLeland, et al.
Clinical Chemistry|August 21, 2003
Development and assessment of a quantitative reverse transcription-PCR assay for simultaneous measurement of four ampliconsMarcy B Grace, Christopher B McLeland, Steven J Gagliardi, et al.
Cancer Research|September 18, 2004
Human in vivo radiation-induced biomarkers: gene expression changes in radiotherapy patientsSally A Amundson, Marcy B Grace, Christopher B McLeland, et al.
Cancer Letters|May 14, 2013
Synergistic combination therapy with nanoliposomal C6-ceramide and vinblastine is associated with autophagy dysfunction in hepatocarcinoma and colorectal cancer modelsPavan P Adiseshaiah, Jeffrey D Clogston, Christopher B McLeland, et al.
Pageof 1